-93.0%
RIVN vs CME
+73.4%
-166.3%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +0.4% | -1.1% | -0.7% |
| 7D | -13.6% | +4.9% | -18.5% | -14.0% |
| 30D | -2.6% | +8.7% | -11.3% | -3.4% |
| 3M | -21.2% | +18.9% | -40.2% | -22.8% |
| 6M | -12.3% | +7.9% | -20.2% | -11.8% |
| YTD | -38.6% | +20.9% | -59.5% | -40.5% |
| 1Y | -19.9% | +16.4% | -36.3% | -21.6% |
| 3Y | -26.2% | +71.0% | -97.2% | -41.1% |
| 5Y | -93.0% | +74.6% | -167.6% | -94.7% |
| All | -93.0% | +73.4% | -166.3% | -94.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling